In particular, FGFR1 is highly activated in nearly 80% of ES samples, probably promoting tumor progression and dissemination by activating the PI3K/AKT, RAS/MAPK, and JAK/STAT signaling pathways [48]. The gene discussed is FGFR1; the disease is neoplasm.